Ouki's drug repurposing intelligence is available to qualifying pharmaceutical companies, biotech firms, and research institutions under commercial agreement.
Note: All substantive enquiries are progressed under a Non-Disclosure Agreement prior to any findings being shared. Access is not automatic — enquiries are reviewed and responded to individually.
Thank you for your enquiry. We will review your request and respond to the email address provided within 2 business days. All follow-up will be conducted under NDA.